These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 28286178

  • 1. Vagus nerve stimulation suppresses acute noxious activation of trigeminocervical neurons in animal models of primary headache.
    Akerman S, Simon B, Romero-Reyes M.
    Neurobiol Dis; 2017 Jun; 102():96-104. PubMed ID: 28286178
    [Abstract] [Full Text] [Related]

  • 2. Oxygen inhibits neuronal activation in the trigeminocervical complex after stimulation of trigeminal autonomic reflex, but not during direct dural activation of trigeminal afferents.
    Akerman S, Holland PR, Lasalandra MP, Goadsby PJ.
    Headache; 2009 Sep; 49(8):1131-43. PubMed ID: 19719541
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory effect of high-frequency greater occipital nerve electrical stimulation on trigeminovascular nociceptive processing in rats.
    Lyubashina OA, Panteleev SS, Sokolov AY.
    J Neural Transm (Vienna); 2017 Feb; 124(2):171-183. PubMed ID: 27677650
    [Abstract] [Full Text] [Related]

  • 4. Characterization of opioidergic mechanisms related to the anti-migraine effect of vagus nerve stimulation.
    Hu B, Akerman S, Goadsby PJ.
    Neuropharmacology; 2021 Sep 01; 195():108375. PubMed ID: 33444636
    [Abstract] [Full Text] [Related]

  • 5. Vagal afferent modulation of spinal trigeminal neuronal responses to dural electrical stimulation in rats.
    Lyubashina OA, Sokolov AY, Panteleev SS.
    Neuroscience; 2012 Oct 11; 222():29-37. PubMed ID: 22800563
    [Abstract] [Full Text] [Related]

  • 6. Pearls and pitfalls in experimental in vivo models of migraine: dural trigeminovascular nociception.
    Akerman S, Holland PR, Hoffmann J.
    Cephalalgia; 2013 Jun 11; 33(8):577-92. PubMed ID: 23671254
    [Abstract] [Full Text] [Related]

  • 7. Targeting the central projection of the dural trigeminovascular system for migraine prophylaxis.
    Akerman S, Romero-Reyes M.
    J Cereb Blood Flow Metab; 2019 Apr 11; 39(4):704-717. PubMed ID: 28885085
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular and neuronal responses to head stimulation reflect central sensitization and cutaneous allodynia in a rat model of migraine.
    Yamamura H, Malick A, Chamberlin NL, Burstein R.
    J Neurophysiol; 1999 Feb 11; 81(2):479-93. PubMed ID: 10036252
    [Abstract] [Full Text] [Related]

  • 9. Episodic dural stimulation in awake rats: a model for recurrent headache.
    Oshinsky ML, Gomonchareonsiri S.
    Headache; 2007 Feb 11; 47(7):1026-36. PubMed ID: 17635594
    [Abstract] [Full Text] [Related]

  • 10. A translational in vivo model of trigeminal autonomic cephalalgias: therapeutic characterization.
    Akerman S, Holland PR, Summ O, Lasalandra MP, Goadsby PJ.
    Brain; 2012 Dec 11; 135(Pt 12):3664-75. PubMed ID: 23065481
    [Abstract] [Full Text] [Related]

  • 11. Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater.
    Bartsch T, Goadsby PJ.
    Brain; 2003 Aug 11; 126(Pt 8):1801-13. PubMed ID: 12821523
    [Abstract] [Full Text] [Related]

  • 12. Predictive validity of endpoints used in electrophysiological modelling of migraine in the trigeminovascular system.
    Farkas B, Kardos P, Orosz S, Tarnawa I, Csekő C, Lévay G, Farkas S, Lendvai B, Kovács P.
    Brain Res; 2015 Nov 02; 1625():287-300. PubMed ID: 26358146
    [Abstract] [Full Text] [Related]

  • 13. The selective 5-HT1F receptor agonist lasmiditan inhibits trigeminal nociceptive processing: Implications for migraine and cluster headache.
    Vila-Pueyo M, Page K, Murdock PR, Loraine HJ, Woodrooffe AJ, Johnson KW, Goadsby PJ, Holland PR.
    Br J Pharmacol; 2022 Feb 02; 179(3):358-370. PubMed ID: 34600443
    [Abstract] [Full Text] [Related]

  • 14. Vagus Nerve Stimulation and Headache.
    Yuan H, Silberstein SD.
    Headache; 2017 Apr 02; 57 Suppl 1():29-33. PubMed ID: 26473407
    [Abstract] [Full Text] [Related]

  • 15. Neuronal PAC1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: Relevance to migraine.
    Akerman S, Goadsby PJ.
    Sci Transl Med; 2015 Oct 07; 7(308):308ra157. PubMed ID: 26446954
    [Abstract] [Full Text] [Related]

  • 16. Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1 receptor: implications for migraine.
    Oliveira MM, Akerman S, Tavares I, Goadsby PJ.
    Pain; 2016 Aug 07; 157(8):1666-1673. PubMed ID: 27023421
    [Abstract] [Full Text] [Related]

  • 17. Comparative effects of traditional Chinese and Western migraine medicines in an animal model of nociceptive trigeminovascular activation.
    Zhao Y, Martins-Oliveira M, Akerman S, Goadsby PJ.
    Cephalalgia; 2018 Jun 07; 38(7):1215-1224. PubMed ID: 28836816
    [Abstract] [Full Text] [Related]

  • 18. Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "triptan" receptors: implications in migraine.
    Akerman S, Holland PR, Lasalandra MP, Goadsby PJ.
    J Neurosci; 2013 Sep 11; 33(37):14869-77. PubMed ID: 24027286
    [Abstract] [Full Text] [Related]

  • 19. The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission.
    Lambert GA, Davis JB, Appleby JM, Chizh BA, Hoskin KL, Zagami AS.
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Oct 11; 380(4):311-25. PubMed ID: 19690836
    [Abstract] [Full Text] [Related]

  • 20. Non-Trigeminal Nociceptive Innervation of the Posterior Dura: Implications to Occipital Headache.
    Noseda R, Melo-Carrillo A, Nir RR, Strassman AM, Burstein R.
    J Neurosci; 2019 Mar 06; 39(10):1867-1880. PubMed ID: 30622169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.